|
24
|
108
|
2coqA |
Structure of new antigen receptor variable domain from sharks |
|
19
|
111
|
2cd0A |
Structure of human lambda-6 light chain dimer wil |
|
51
|
217
|
2c1pA |
Fab-fragment of enantioselective antibody complexed with finrozole |
|
50
|
217
|
2c1oA |
Enaiihis fab fragment in the free form |
|
40
|
203
|
2bnuA |
Structural and kinetic basis for heightened immunogenicity of t cell vaccines |
|
16
|
106
|
2bx5A |
Is fr1 the antibody's achillies heel |
|
42
|
203
|
2bnrD |
Structural and kinetic basis for heightened immunogenicity of t cell vaccines |
|
25
|
119
|
2bveA |
Structure of the n-terminal of sialoadhesin in complex with 2-phenyl- prop5ac |
|
58
|
241
|
2bnqE |
Structural and kinetic basis for heightened immunogenicity of t cell vaccines |
|
42
|
203
|
2bnqD |
Structural and kinetic basis for heightened immunogenicity of t cell vaccines |
|
59
|
241
|
2bnrE |
Structural and kinetic basis for heightened immunogenicity of t cell vaccines |
|
56
|
241
|
2bnuB |
Structural and kinetic basis for heightened immunogenicity of t cell vaccines |
|
26
|
115
|
2atpB |
Crystal structure of a cd8ab heterodimer |
|
23
|
110
|
2bjmL |
Spe7:anthrone complex |
|
46
|
224
|
2ai0H |
Anti-cocaine antibody 7.5.21, crystal form iii |
|
19
|
118
|
2atpA |
Crystal structure of a cd8ab heterodimer |
|
42
|
219
|
2ajuH |
Cyrstal structure of cocaine catalytic antibody 7a1 fab' |
|
23
|
187
|
2aepH |
An epidemiologically significant epitope of a 1998 influenza virus neuraminidase forms a highly hydrated interface in the na-antibody complex. |
|
27
|
109
|
2aq3A |
Crystal structure of t-cell receptor v beta domain variant complexed with superantigen sec3 |
|
43
|
219
|
2ajyH |
Crystal structure of cocaine catalytic antibody 7a1 fab' in complex with ecgonine methyl ester and benzoic acid |
|
43
|
219
|
2ajsH |
Crystal structure of cocaine catalytic antibody 7a1 fab' in complex with heptaethylene glycol |
|
41
|
219
|
2ajvH |
Crystal structure of cocaine catalytic antibody 7a1 fab' in complex with cocaine |
|
29
|
171
|
2aepL |
An epidemiologically significant epitope of a 1998 influenza virus neuraminidase forms a highly hydrated interface in the na-antibody complex. |
|
15
|
119
|
2arjQ |
Cd8alpha-alpha in complex with yts 105.18 fab |
|
46
|
218
|
2adfH |
Crystal structure and paratope determination of 82d6a3, an antithrombotic antibody directed against the von willebrand factor a3-domain |
|
35
|
109
|
2aq1A |
Crystal structure of t-cell receptor v beta domain variant complexed with superantigen sec3 mutant |
|
41
|
215
|
2agjL |
Crystal structure of a glycosylated fab from an igm cryoglobulin with properties of a natural proteolytic antibody |
|
40
|
219
|
2ajxH |
Crystal structure of cocaine catalytic antibody 7a1 fab' in complex with transition state analog |
|
16
|
116
|
2aeqH |
An epidemiologically significant epitope of a 1998 influenza virus neuraminidase forms a highly hydrated interface in the na-antibody complex. |
|
32
|
110
|
2aq2A |
Crystal structure of t-cell receptor v beta domain variant complexed with superantigen sec3 mutant |
|
43
|
219
|
2ak1H |
Crystal structure of cocaine catalytic antibody 7a1 fab' in complex with benzoic acid |
|
45
|
216
|
1zeaH |
Structure of the anti-cholera toxin antibody fab fragment te33 in complex with a d-peptide |
|
29
|
110
|
1zoxA |
Clm-1 mouse myeloid receptor extracellular domain |
|
54
|
213
|
1zanL |
Crystal structure of anti-ngf ad11 fab |
|
52
|
216
|
1zeaL |
Structure of the anti-cholera toxin antibody fab fragment te33 in complex with a d-peptide |
|
47
|
216
|
2a1wL |
Anti-cocaine antibody 7.5.21, crystal form i |
|
45
|
225
|
2a1wH |
Anti-cocaine antibody 7.5.21, crystal form i |
|
23
|
104
|
1z9mA |
Crystal structure of nectin-like molecule-1 protein domain 1 |
|
42
|
222
|
1zanH |
Crystal structure of anti-ngf ad11 fab |
|
61
|
344
|
1za6B |
The structure of an antitumor ch2-domain-deleted humanized antibody |
|
40
|
219
|
1ynkH |
Identification of key residues of the nc6.8 fab antibody fragment binding to synthetic sweeteners: crystal structure of nc6.8 co-crystalized with high potency sweetener compound sc45647 |
|
50
|
219
|
1yeiL |
Catalytic antibody d2.3 complex |
|
49
|
219
|
1yejL |
Catalytic antibody complex |
|
49
|
219
|
1yekL |
Catalytic antibody d2.3 complex |
|
42
|
219
|
1ynlH |
Identification of key residues of the nc6.8 fab antibody fragment binding to synthetic sweeterners: crystal structure of nc6.8 co-crystalized with high potency sweetener compound sc45647 |
|
48
|
219
|
1ynkL |
Identification of key residues of the nc6.8 fab antibody fragment binding to synthetic sweeteners: crystal structure of nc6.8 co-crystalized with high potency sweetener compound sc45647 |
|
52
|
219
|
1ynlL |
Identification of key residues of the nc6.8 fab antibody fragment binding to synthetic sweeterners: crystal structure of nc6.8 co-crystalized with high potency sweetener compound sc45647 |
|
38
|
218
|
1xgyH |
Crystal structure of anti-meta i rhodopsin fab fragment k42-41l |
|
31
|
135
|
1xt5A |
Crystal structure of vcbp3, domain 1, from branchiostoma floridae |
|
25
|
108
|
1wtlA |
Comparison of crystal structures of two homologous proteins: structural origin of altered domain interactions in immunoglobulin light chain dimers |
